Effects of Oleacein, a New Epinutraceutical Bioproduct from Extra Virgin Olive Oil, in LPS-Activated Murine Immune Cells.
epigenetic
histone
immunity
inflammation
macrophages
oleacein
olive oil
spleen cells
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
28 Oct 2022
28 Oct 2022
Historique:
received:
08
10
2022
revised:
25
10
2022
accepted:
26
10
2022
entrez:
10
11
2022
pubmed:
11
11
2022
medline:
11
11
2022
Statut:
epublish
Résumé
The present study was designed to evaluate the immunomodulatory effects of the secoiridoid from extra virgin olive oil, oleacein (OLA), deepening into the possible signaling pathways involved in LPS-activated murine peritoneal macrophages. Moreover, we have explored OLA-induced epigenetic changes in histone markers and related cytokine production in murine LPS-stimulated murine splenocytes. Murine cells were treated with OLA in the presence or absence of LPS (5 μg/mL) for 18 or 24 h. OLA modulated the oxidative stress and the inflammatory response produced by LPS stimulation in murine peritoneal macrophages, by the inhibition of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, IFN-γ, IL-17 and IL-18) and ROS production and the expression of pro-inflammatory enzymes such as iNOS, COX-2 and m-PGES1. These protective effects could be due to the activation of the Nrf-2/HO-1 axis and the inhibition of JAK/STAT, ERK and P38 MAPKs and inflammasome canonical and non-canonical signaling pathways. Moreover, OLA modulated epigenetic modifications throughout histone methylation deacetylation (H3K18ac) and (H3K9me3 and H3K27me) in LPS-activated spleen cells. In conclusion, our data present OLA as an interesting anti-inflammatory and antioxidant natural compound that is able to regulate histone epigenetic markers. Nevertheless, additional in vivo studies are required to further investigate the beneficial effects of this EVOO secoiridoid, which might be a promising epinutraceutical bioproduct for the management of immune-related inflammatory diseases.
Identifiants
pubmed: 36355509
pii: ph15111338
doi: 10.3390/ph15111338
pmc: PMC9699377
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Economy, Industry and Competitiveness
ID : AG-2017-89342-P
Références
J Ethnopharmacol. 2014;151(1):131-6
pubmed: 24239848
Antioxidants (Basel). 2020 Nov 21;9(11):
pubmed: 33233421
Nat Rev Immunol. 2013 Sep;13(9):679-92
pubmed: 23954936
J Agric Food Chem. 2001 Mar;49(3):1218-23
pubmed: 11312839
Biomed Pharmacother. 2022 Jan;145:112468
pubmed: 34847479
Cell Physiol Biochem. 2012;29(1-2):9-20
pubmed: 22415070
Immunity. 2019 Dec 17;51(6):997-1011.e7
pubmed: 31851905
Antioxidants (Basel). 2020 Feb 10;9(2):
pubmed: 32050687
Antioxidants (Basel). 2021 Sep 08;10(9):
pubmed: 34573062
Front Endocrinol (Lausanne). 2018 Mar 19;9:116
pubmed: 29615982
Mediators Inflamm. 2020 Apr 13;2020:1583647
pubmed: 32351318
Clin Immunol. 2018 Nov;196:3-11
pubmed: 29425851
Cell Death Dis. 2017 Oct 5;8(10):e3074
pubmed: 28981106
Int J Mol Sci. 2021 Jul 15;22(14):
pubmed: 34299198
Cancers (Basel). 2019 Jul 16;11(7):
pubmed: 31315220
Anim Sci J. 2019 Jan;90(1):140-148
pubmed: 30460722
Gen Physiol Biophys. 2019 Jul;38(4):315-324
pubmed: 31241043
Oxid Med Cell Longev. 2020 Feb 17;2020:4063562
pubmed: 32148650
Toxicol In Vitro. 2018 Oct;52:243-250
pubmed: 29959992
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Food Funct. 2020 Jul 22;11(7):6622-6631
pubmed: 32656558
Heart Vessels. 2020 Dec;35(12):1746-1754
pubmed: 32676696
Immunology. 2018 Jun;154(2):186-195
pubmed: 29455468
J Nat Prod. 2014 Mar 28;77(3):441-5
pubmed: 24568174
Food Funct. 2020 Apr 30;11(4):3271-3279
pubmed: 32219291
Essays Biochem. 2010 Sep 20;48(1):121-46
pubmed: 20822491
J Immunol. 2020 Jun 15;204(12):3063-3069
pubmed: 32513874
Nutrients. 2019 Aug 07;11(8):
pubmed: 31394876
Free Radic Biol Med. 1999 May;26(9-10):1231-7
pubmed: 10381194
Phytomedicine. 2017 Aug 15;32:68-73
pubmed: 28732809
Front Pharmacol. 2020 Sep 23;11:574317
pubmed: 33071785
Biochim Biophys Acta Mol Cell Res. 2019 Mar;1866(3):474-485
pubmed: 30321616
Evid Based Complement Alternat Med. 2020 May 3;2020:2837853
pubmed: 32454852
J Nutr Biochem. 2013 Aug;24(8):1513-9
pubmed: 23477728
J Agric Food Chem. 2015 Jan 28;63(3):836-46
pubmed: 25526103
Antioxidants (Basel). 2019 Dec 24;9(1):
pubmed: 31878334
Antioxidants (Basel). 2021 Dec 27;11(1):
pubmed: 35052558
J Agric Food Chem. 2019 May 15;67(19):5552-5559
pubmed: 31042377
Mediators Inflamm. 2019 Sep 4;2019:9184769
pubmed: 31565034
Respir Res. 2015 Aug 05;16:95
pubmed: 26243279
Carcinogenesis. 2018 Apr 5;39(4):601-613
pubmed: 29452350
Braz J Med Biol Res. 2018 Aug 16;51(10):e7439
pubmed: 30156611
J Nutr Biochem. 2018 Jul;57:110-120
pubmed: 29694939
Cell Discov. 2020 Jun 9;6:36
pubmed: 32550001
Mar Drugs. 2021 Nov 27;19(12):
pubmed: 34940676
Nutrients. 2019 Nov 21;11(12):
pubmed: 31766503
Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):57-63
pubmed: 31621560
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Front Immunol. 2019 Jul 04;10:1525
pubmed: 31333659
Phytomedicine. 2019 Jun;59:152785
pubmed: 31009850
Nutr Res Rev. 2021 Aug 16;:1-21
pubmed: 34392862
Nutrients. 2019 Jul 19;11(7):
pubmed: 31331073
Int J Mol Sci. 2022 Jan 21;23(3):
pubmed: 35163130
Shock. 2019 Mar;51(3):401-406
pubmed: 29570119
Pharmaceuticals (Basel). 2020 Apr 09;13(4):
pubmed: 32283795